| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The validity of estimations of plasma fatty acid oxidation using tracers has often been questioned. The appearance of isotopic markers in breath CO2 is delayed and incomplete. Recently suggestions have been made that substantial amounts of tracer are incorporated into products of the tricarboxylic acid cycle (e.g. glucose, glutamine and glutamate) and that an acetate correction factor can be used to correct for tracer fixation. In the present study we investigated whether the appearance of 13CO2 during a separate infusion of [1,2-13C]acetate could be used for correction of [U-13C]palmitate oxidation rates in studies lasting <2 h and we quantified the appearance of tracer in the glutamine, glutamate and glucose pools of the body.
An infusion of either [1,2-13C]acetate (0·104 µmol min-1 kg-1) or [U-13C]palmitate (0·013 µmol min-1 kg-1) was given to eight male subjects and continued for 2 h at rest. In six subjects the infusion of [1,2-13C]acetate was repeated to determine reproducibility of the acetate recovery.
Fractional recovery in breath from [1,2-13C]acetate gradually increased during the infusion period at rest from 14·1 ± 0·6 % at 60 min to 26·5 ± 0·5 % at 120 min after the start of the infusion. Intersubject coefficient of variance was 8·3 ± 0·6 % and intrasubject coefficient of variance of the acetate recovery tests was 4·0 ± 1·5 %. After 2 h of [1,2-13C]acetate infusion, 12·4 ± 0·8 and 10·3 ± 0·9 % of infused 13C was incorporated in the glutamine and glutamate pools, respectively.
In conclusion, the [1,2-13C]acetate recovery factor can be used for correcting the rate of [U-13C]palmitate oxidation in infusing studies of 2 h in resting conditions. Failure to use this recovery factor leads to a substantial underestimation of the rate of plasma free fatty acid oxidation. The extent of label fixation could largely be explained by accumulation of tracer carbon in glutamine and glutamate, and the accumulation in glucose is negligible.
This article has been cited by other articles:
|
|
 |
|
  A. Bergouignan, D. A. Schoeller, S. Votruba, C. Simon, and S. Blanc The acetate recovery factor to correct tracer-derived dietary fat oxidation in humans Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E645 - E653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Y. Fram, M. G. Cree, D. L. Chinkes, D. N. Herndon, and R. R. Wolfe Recovery of labeled CO2 from acetate in severely burned children Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1726 - E1729. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Raman, S. Blanc, A. Adams, and D. A. Schoeller Validation of deuterium-labeled fatty acids for the measurement of dietary fat oxidation during physical activity J. Lipid Res., December 1, 2004; 45(12): 2339 - 2344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. C. van Loon Use of intramuscular triacylglycerol as a substrate source during exercise in humans J Appl Physiol, October 1, 2004; 97(4): 1170 - 1187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ruzzin, F. Peronnet, J. Tremblay, D. Massicotte, and C. Lavoie Breath [13CO2] recovery from an oral glucose load during exercise: comparison between [U-13C] and [1,2-13C]glucose J Appl Physiol, August 1, 2003; 95(2): 477 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Schrauwen, D. P.C. van Aggel-Leijssen, G. Hul, A. J.M. Wagenmakers, H. Vidal, W. H.M. Saris, and M. A. van Baak The Effect of a 3-Month Low-Intensity Endurance Training Program on Fat Oxidation and Acetyl-CoA Carboxylase-2 Expression Diabetes, July 1, 2002; 51(7): 2220 - 2226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. C. Van Aggel-Leijssen, W. H. M. Saris, A. J. M. Wagenmakers, J. M. Senden, and M. A. Van Baak Effect of exercise training at different intensities on fat metabolism of obese men J Appl Physiol, March 1, 2002; 92(3): 1300 - 1309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. E. Blaak and A. J.M. Wagenmakers The Fate of [U-13C]Palmitate Extracted by Skeletal Muscle in Subjects With Type 2 Diabetes and Control Subjects Diabetes, March 1, 2002; 51(3): 784 - 789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Roepstorff, C. H. Steffensen, M. Madsen, B. Stallknecht, I.-L. Kanstrup, E. A. Richter, and B. Kiens Gender differences in substrate utilization during submaximal exercise in endurance-trained subjects Am J Physiol Endocrinol Metab, February 1, 2002; 282(2): E435 - E447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Trimmer, G. A. Casazza, M. A. Horning, and G. A. Brooks Recovery of 13CO2 during rest and exercise after [1-13C]acetate, [2-13C]acetate, and NaH13CO3 infusions Am J Physiol Endocrinol Metab, October 1, 2001; 281(4): E683 - E692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. B. Borghouts, P. Schrauwen, E. E. Blaak, A. J. M. Wagenmakers, J. F. Horowitz, and S. Klein Differences in Acetate Recovery Factor Between Groups May Interfere With Tracer Estimates of Fat Oxidation J Appl Physiol, June 1, 2001; 90(6): 2520 - 2521. [Full Text] [PDF]
|
|
|
|
|
|
Z. Guo, B. Burguera, and M. D. Jensen Kinetics of intramuscular triglyceride fatty acids in exercising humans J Appl Physiol, November 1, 2000; 89(5): 2057 - 2064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. E. Blaak, A. J. M. Wagenmakers, J. F. C. Glatz, B. H. R. Wolffenbuttel, G. J. Kemerink, C. J. M. Langenberg, G. A. K. Heidendal, and W. H. M. Saris Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E146 - E154. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
